NCT07204691 - A Study to Evaluate the Safety and Performance of Dr Korman Laboratories' Hyaluronic Acid Filler 20 mg/mL With Lidocaine for Lip Augmentation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 24, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2027

Conditions

Lip Augmentation

Interventions

DEVICE

DKL crosslinked sodium hyaluronate 20 mg/mL + Lidocaine 0.3% dermal filler

DKL crosslinked sodium hyaluronate 20 mg/mL + lidocaine 0.3% dermal filler is an injectable sterile, non-pyrogenic gel composed of crosslinked sodium hyaluronate of a non-animal origin and lidocaine in a phosphate-buffered saline solution.

Trial Locations (2)

SE-431 53

Clinical Trial Consultants AB (CTC) GoCo, Mölndal

SE-171 64

CTC Stockholm, Solna